ENCYSIVE PHARMACEUTICALS INC (ENCY) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 132 transactions totaling $17.8M, demonstrating a bullish sentiment with $17.5M in net insider flow. The most recent transaction on Apr 14, 2008 involved a purchase of 1,232,412 shares valued at $2.9M.
No significant insider buying has been recorded for ENCY in the recent period.
No significant insider selling has been recorded for ENCY in the recent period.
Based on recent SEC filings, insider sentiment for ENCY is bullish with an Insider Alignment Score of 99/100 and a net flow of $17.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ENCYSIVE PHARMACEUTICALS INC (ENCY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading ENCY stock, having executed 132 transactions in the past 90 days. The most active insider is Inc Pfizer (Executive), who has made 12 transactions totaling $17.6M.
Get notified when executives and directors at ENCY file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 14, 2008 | Pfizer Inc | Executive | Purchase | 1,232,412 | $2.35 | $2.9M | Large |
| Apr 11, 2008 | Pfizer Inc | Executive | Purchase | 155,499 | $2.35 | $365.4K | |
| Apr 10, 2008 | Pfizer Inc | Executive | Purchase | 210,794 | $2.35 | $495.4K | |
| Apr 9, 2008 | Pfizer Inc | Executive | Purchase | 12,628 | $2.35 | $29.7K | |
| Apr 8, 2008 | Pfizer Inc | Executive | Purchase | 29,407 | $2.35 | $69.1K | |
| Apr 7, 2008 | Pfizer Inc | Executive | Purchase | 2,203,420 | $2.35 | $5.2M | Large |
| Apr 4, 2008 | Pfizer Inc | Executive | Purchase | 576,170 | $2.35 | $1.4M | Large |
| Apr 3, 2008 | Pfizer Inc | Executive | Purchase | 1,809,663 | $2.35 | $4.3M | Large |
| Apr 2, 2008 | Pfizer Inc | Executive | Purchase | 6,002 | $2.35 | $14.1K | |
| Apr 2, 2008 | Pfizer Inc | Executive | Purchase | 914,512 | $2.35 | $2.1M | Large |
| Apr 1, 2008 | J. Anderson Ronald | Executive | Tender | 17,218 | $2.35 | $40.5K | |
| Apr 1, 2008 | Kevin Buchi J. | Executive | Tender | 11,253 | $2.35 | $26.4K | |
| Apr 1, 2008 | W. Cole George | Executive | Tender | 272,589 | $2.35 | $640.6K | Large |
| Apr 1, 2008 | J. Cruikshank Robert | Executive | Tender | 63,376 | $2.35 | $148.9K | |
| Apr 1, 2008 | H. Dillon John II | Executive | Tender | 9,121 | $2.35 | $21.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 12 | $17.6M | 81.5% |
Tender(U) | 18 | $3.8M | 17.7% |
Sale(S) | 4 | $147.1K | 0.7% |
Exercise(M) | 2 | $30.0K | 0.1% |
Award(A) | 57 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Other(J) | 38 | $0 | 0.0% |
Insiders at ENCYSIVE PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 20 insiders making 132 transactions totaling $17.6M in purchases versus $147.1K in sales, the net buying activity of $17.5M signals strong executive confidence. Inc Pfizer (Executive) leads the buying activity with $17.6M in transactions across all time.